| 09:30 - 11:30 | 40 | French programme 2021 | Language session |
| 09:30 - 11:00 | 41 | Vaccination and infections | Joint session |
| 09:30 - 11:00 | 42 | Highlights for primary care in 2021 | Oral Presentation |
| 09:30 - 11:00 | 43 | Chronic COVID - 19 | Oral Presentation |
| 09:30 - 11:00 | 44 | Environment and respiratory health | Oral Presentation |
| 09:30 - 11:00 | 45 | Repair and regeneration in chronic lung disease and lung cancer | Symposium |
| 09:30 - 11:00 | 46 | Airway diseases | State of the art session |
| 09:30 - 11:00 | 47 | New developments in mechanical ventilation and ventilator weaning | Symposium |
| 09:30 - 11:00 | 48 | Holistic care in interstitial lung disease: monitoring the patient’s pathway | Symposium |
| 09:30 - 11:00 | 49 | LoF Paediatric respiratory diseases | Lungs on fire |
| 09:30 - 11:00 | 50 | All about pulmonary arterial hypertension | Oral Presentation |
| 10:00 - 12:00 | 51 | Cardiopulmonary exercise testing | Skills lab |
| 11:15 - 12:45 | 57 | Best abstracts in pulmonary rehabilitation and chronic care | Oral Presentation |
| 11:15 - 12:45 | 58 | Non-pulmonary arterial hypertension pulmonary hypertension | Oral Presentation |
| 11:15 - 12:45 | 59 | Psychological and behavioural issues in respiratory care | Oral Presentation |
| 11:15 - 12:45 | 60 | Noninvasive respiratory support in hypoxic respiratory failure: stay safe and know your limits | Symposium |
| 11:15 - 12:45 | 61 | Innate immunity and lung epithelial repair: what really happens? | Symposium |
| 11:15 - 12:45 | 62 | ALERT: COPD | Clinical trials session |
| 11:15 - 12:45 | 63 | Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment | Symposium |
| 11:15 - 11:55 | 64 | Post COVID interstitial lung diseases syndrome: diagnosis and management as interstitial lung disease? | Pro-Con debate |
| 11:15 - 11:55 | 65 | ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis | Guidelines session |
| 11:15 - 12:45 | 66 | Novelties in interventional pulmonology | Oral Presentation |
| 11:45 - 13:00 | 67 | CCC Respiratory infections | Challenging clinical cases |
| 12:05 - 12:45 | 70 | ERS clinical practice guidelines on treatment of sarcoidosis | Guidelines session |
| 12:05 - 12:45 | 71 | The ERS guidelines for the diagnosis of asthma in children aged 5-16 years | Guidelines session |
| 13:00 - 15:00 | 77 | Continuous positive airway pressure, non-invasive ventilation and mechanical ventilation | Skills lab |
| 13:00 - 14:30 | 79 | Transforming respiratory care: why now is the time to act | Joint session |
| 13:15 - 14:15 | 83 | Clinical features and challenges of COVID-19 | E-poster |
| 13:15 - 14:15 | 84 | Pulmonary rehabilitation in asthma and COPD | E-poster |
| 13:15 - 14:15 | 85 | Symptoms across respiratory diseases and impact of COVID-19 | E-poster |
| 13:15 - 14:15 | 86 | Novel imaging analysis methodologies in diffuse lung diseases | E-poster |
| 13:15 - 14:15 | 87 | Pathophysiology and clinical consequences of obstructive sleep apnoea | E-poster |
| 13:15 - 14:15 | 88 | Biomarkers and e-health in idiopathic interstitial pneumonia | E-poster |
| 13:15 - 14:15 | 89 | Hypoxia, exercise and respiratory function in pathophysiological conditions | E-poster |
| 13:15 - 14:15 | 90 | Thoracic surgery, lung cancer and complications of COVID-19 | E-poster |
| 13:15 - 14:15 | 91 | Diagnosis and management of COVID-19 | E-poster |
| 13:15 - 14:15 | 92 | News in treatment and diagnosis of idiopathic interstitial pneumonia | E-poster |
| 13:15 - 14:15 | 93 | Challenges of COVID-19 management at short and long-term | E-poster |
| 13:15 - 14:15 | 94 | Pulmonary embolism in non-COVID-19 and COVID-19 patients | E-poster |
| 13:15 - 14:15 | 95 | COVID - 19: lessons learned | E-poster |
| 13:15 - 14:15 | 96 | Medical education in respiratory medicine | E-poster |
| 13:15 - 14:15 | 97 | Airway pharmacology: translational and basic science | E-poster |
| 13:15 - 14:15 | 98 | Posters in paediatric bronchology | E-poster |
| 13:15 - 14:15 | 99 | Pathogenesis and pathophysiology of pulmonary hypertension | E-poster |
| 13:15 - 14:15 | 100 | Pulmonary rehabilitation in the COVID-19 era | E-poster |
| 13:15 - 14:15 | 101 | Asthma burden and management I | E-poster |
| 13:15 - 14:15 | 102 | COVID - 19 biomarkers | E-poster |
| 13:15 - 14:15 | 103 | Novel insights into the pathogenesis of chronic lung diseases | E-poster |
| 13:15 - 14:15 | 104 | New insights into the airway immunology of lung disease | E-poster |
| 13:15 - 14:15 | 105 | Moving forward in various aspects of sarcoidosis | E-poster |
| 13:15 - 14:15 | 106 | Developments in biomarkers and treatment strategies for chronic lung diseases | E-poster |
| 13:15 - 14:15 | 107 | Advances in therapeutic plans for sleep disordered breathing | E-poster |
| 13:15 - 14:15 | 108 | Respiratory physiotherapy: e-health, activities of daily living and measurement properties of instruments | E-poster |
| 13:15 - 14:15 | 109 | Peripheral muscle function, exercise capacity and functional status in respiratory disease | E-poster |
| 13:15 - 14:15 | 110 | Inhaled treatments for COPD: clinical trials and real-world studies | E-poster |
| 13:15 - 14:15 | 111 | COVID – 19: treatments and predictive factors | E-poster |
| 13:15 - 14:15 | 112 | New insight into the immunology of allergies, asthma and COPD: from mouse to man | E-poster |
| 13:15 - 14:15 | 113 | Bronchoscopy in the COVID - 19 era: cryobiopsy | E-poster |
| 13:15 - 14:15 | 114 | Emerging new mechanisms of chronic lung disease | E-poster |
| 13:15 - 14:15 | 115 | Asthma clinical trials and real-life studies | E-poster |
| 13:15 - 14:15 | 116 | COVID-19 and acute respiratory failure | E-poster |
| 13:15 - 14:15 | 117 | Burden and epidemiology of COVID-19 | E-poster |
| 13:15 - 14:15 | 118 | The different faces of sleep disturbances in respiratory diseases and beyond | E-poster |
| 13:15 - 14:15 | 119 | COVID-19 and obstructive diseases: risk factors, management and long-term effects | E-poster |
| 13:15 - 14:15 | 120 | Patient-reported outcomes in respiratory disease | E-poster |
| 13:15 - 14:15 | 121 | Respiratory physiology and breathing during sleep in health and sickness | E-poster |
| 13:15 - 14:15 | 122 | Primary care organisation and epidemiology | E-poster |
| 13:15 - 14:15 | 123 | Tuberculosis, COVID-19 and other comorbidities | E-poster |
| 13:15 - 14:15 | 124 | Challenges and advances in the diagnosis and clinical management of tuberculosis | E-poster |
| 13:15 - 14:15 | 125 | Lung function evaluation and assessment of airway diseases | E-poster |
| 13:15 - 14:15 | 126 | Non-invasive respiratory support in COVID-19 | E-poster |
| 13:15 - 14:15 | 127 | Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments | E-poster |
| 13:15 - 14:15 | 128 | Biology of lung cancer: preclinical and translational research | E-poster |
| 13:15 - 14:15 | 129 | Biomarkers for the management of bronchial obstructive diseases | E-poster |
| 13:15 - 14:15 | 130 | Long COVID - 19 | E-poster |
| 14:30 - 15:45 | 131 | CCC Paediatric respiratory diseases | Challenging clinical cases |
| 14:45 - 16:15 | 132 | COVID-19: insights from respiratory physiotherapists | Oral Presentation |
| 14:45 - 16:15 | 133 | Clinical trials in airway diseases: novel treatments and new evidence | Oral Presentation |
| 14:45 - 16:15 | 134 | The future of idiopathic pulmonary fibrosis | Oral Presentation |
| 14:45 - 16:15 | 135 | Mechanistic pathways in chronic and new lung diseases | Oral Presentation |
| 14:45 - 16:15 | 136 | Digital health in respiratory medicine: opportunities for everyone | Symposium |
| 14:45 - 16:15 | 137 | Respiratory infections | State of the art session |
| 14:45 - 16:15 | 138 | Diagnostic and therapeutic advances in mesothelioma care | Symposium |
| 14:45 - 16:15 | 139 | Environment, air pollution, health and respiratory disease | Hot topics |
| 14:45 - 16:15 | 140 | LoF Pulmonary vascular diseases? | Lungs on fire |
| 14:45 - 16:15 | 141 | COVID-19 acute respiratory distress syndrome | Oral Presentation |
| 16:00 - 18:00 | 143 | Spanish/Portuguese programme 2021 | Language session |
| 16:30 - 18:00 | 149 | Deep phenotyping of obstructive diseases for precision medicine | Oral Presentation |
| 16:30 - 18:00 | 150 | Best of paediatric physiology and sleep research | Oral Presentation |
| 16:30 - 18:00 | 151 | Bronchiectasis heterogeneity: assessing the endotypes | Oral Presentation |
| 16:30 - 18:00 | 152 | New evidence from longitudinal asthma cohorts and other key studies | Oral Presentation |
| 16:30 - 18:00 | 154 | Digital health meets sleep breathing disorders | Symposium |
| 16:30 - 18:00 | 155 | Imaging grand round | Grand round |
| 16:30 - 18:00 | 156 | Lung graft allocation and monitoring in the 21st century | Symposium |
| 16:30 - 18:00 | 157 | Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening | Journal session |
| 16:30 - 18:00 | 158 | Pulmonary embolism: controversies in management | Respiratory medicine meets other disciplines |
| 16:30 - 18:00 | 159 | Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier | Oral Presentation |